Iparomlimab
Previously Treated HER2-negative Breast Cancer Patients With Homologous Recombination Deficiency
The First Affiliated Hospital with Nanjing Medical UniversityPhase 2
—
Rating in progress
Iparomlimab in Previously Treated HER2-negative Breast Cancer Patients With Homologous Recombination Deficiency is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Active